Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression

Abstract

A better understanding of changes in gene expression during ovarian tumorigenesis and the identification of specific tumor markers may lead to novel strategies for diagnosis and therapy for this disease. Using our serial analysis of gene expression (SAGE) data, as well as public SAGE databases that contained a total of 137 SAGE libraries representing a wide variety of normal and neoplastic tissues, we identified five novel SAGE tags specifically expressed in ovarian cancer. Database analysis, cloning and, sequencing of the corresponding expressed sequence tags revealed details about these transcripts that we named human ovarian cancer-specific transcripts (HOSTs). HOST1 was found to be identical to the gene encoding ovarian marker CA125 (MUC16). HOST2 is a novel gene containing multiple copies of retroviral-related sequences without an obvious open reading frame. HOST3 encodes the tight-junction protein claudin-16 (CLDN16). HOST4 encodes a poorly characterized proteoglycan link protein (LP), and HOST5 codes for a type II sodium-dependent phosphate transporter (SLC34A2). Except for MUC16, these genes have not previously been shown to be expressed in ovarian or other cancers. Northern blot analysis confirmed that HOST genes are rarely expressed in normal tissues or nonovarian cancers, but are frequently expressed in ovarian cancer-derived cell lines and primary tumors. Moreover, HOST genes are upregulated in all four major subtypes of ovarian cancer compared to cultivated ovarian surface epithelial cells, as concluded by real-time reverse transcription (RT)–PCR using a panel of microdissected ovarian tumors. The sodium-dependent phosphate transporter (HOST5/SLC34A2) expression was associated with increased differentiation in ovarian serous tumors. While the roles of HOSTs in ovarian malignant transformation remain unclear, we propose that HOSTs may represent alternative targets for diagnosis and therapy and of this deadly disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

RT–PCR:

reverse transcription–PCR

SAGE:

serial analysis of gene expression

HOST:

human ovarian-specific transcript

NaPi transporter:

sodium-dependent phosphate transporter

References

  • Bast RC, Feeney M, Lazarus H, Nadler LM, Colvin RB and Knapp RC . (1981). J. Clin. Invest., 68, 1331–1337.

  • Bast RC, Xu FJ, Yu YH, Barnhill S, Zhang Z and Mills GB . (1998). Int. J. Biol. Markers, 13, 179–187.

  • Berek JS, Bertelsen K, du Bois A, Brady MF, Carmichael J, Eisenhauer EA, Gore M, Grenman S, Hamilton TC, Hansen SW, Harper PG, Horvath G, Kaye SB, Luck HJ, Lund B, McGuire WP, Neijt JP, Ozols RF, Parmar MK, Piccart-Gebhart MJ, van Rijswijk R, Rosenberg P, Rustin GJ, Sessa C, Thigpen JT, Trope C, Tuxen MK, Vergote I, Vermorken JB and Willemse PHB . (1999). Ann. Oncol., 10, 87–92.

  • Boon K, Osório EC, Greenhut SF, Schaefer CF, Shoemaker J, Polyak K, Morin PJ, Buetow K, Strausberg RL, de Souza SJ and Riggins GJ . (2002). Proc. Natl. Acad. Sci. USA, 99, 11287–11292.

  • Eisen MB, Spellman PT, Brown PO and Botstein D . (1998). Proc. Natl. Acad. Sci. USA, 95, 14863–14868.

  • Erdmann VA, Szymanski M, Hochberg A, Groot N and Barciszewski J . (2000). Nuc. Acids Res., 28, 197–200.

  • Folz RJ and Nepluev I . (2000). Biotechniques, 29, 762–768.

  • Gregoire L, Munkarah A, Rabah R, Morris RT and Lancaster WD . (1998). In vitro Cell Dev. Biol. Anim., 34, 636–639.

  • Hao Y, Crenshaw T, Moulton T, Newcomb E and Tycko B . (1993). Nature, 365, 764–767.

  • Hashimoto M, Wang DY, Kamo T, Zhu Y, Tsujiuchi T, Konishi Y, Tanaka M and Sugimura H . (2000). Am. J. Pathol., 157, 21–27.

  • Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, Drescher C, Urban N and Hellstrom KE . (2003). Cancer Res., 63, 3695–3700.

  • Hoskins WJ . (1995). J. Cell. Biochem. Suppl., 23, 189–199.

  • Hough CD, Cho KR, Zonderman AB, Schwartz DR and Morin PJ . (2001). Cancer Res., 61, 3869–3876.

  • Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ and Morin PJ . (2000). Cancer Res., 60, 6281–6287.

  • Ismail RS, Baldwin RL, Fang J, Browning D, Karlan BY, Gasson JC and Chang DD . (2000). Cancer Res., 60, 6744–6749.

  • Lal A, Lash AE, Altschul AF, Velculescu VE, Zhang L, McLendon RE, Marra MA, Prange C, Morin PJ, Papadopoulos N, Vogelstein B, Kinzler KW, Strausberg RL and Riggins GJ . (1999). Cancer Res., 59, 5403–5407.

  • Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ . (2002). Carcinogenesis, 23, 1885–1895.

  • Luo MP, Gomperts B, Imren S, DeClerck YA, Ito M, Velicescu M, Felix JC and Dubeau L . (1997). Gynecol. Oncol., 67, 277–284.

  • Makar AP, Baekelandt M, Trope CG and Kristensen GB . (1995). Gynecol. Oncol., 56, 175–180.

  • Mann WJ, Patsner B, Cohen H and Loesch M . (1988). J. Natl. Cancer Inst., 80, 208–209.

  • Mashima H, Zhang YQ, Tajima T, Takeda J and Kojima I . (2001). Diabetes, 50 (Suppl. 1), S39.

  • Mazurek A, Niklinski J, Laudanski T and Pluygers E . (1998). Eur. J. Cancer Prev., 7, 23–35.

  • Murer H, Hernando N, Forster I and Biber J . (2000). Physiol. Rev., 80, 1373–1409.

  • Ozols RF, Garvin AJ, Costa J, Simon RM and Young RC . (1980). Cancer, 45, 572–581.

  • Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC and Liotta LA . (2002). Lancet, 359, 572–577.

  • Rangel LBA, Agarwal R, D'Souza T, Pizer ES, Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR and Morin PJ . (2003). Clin. Cancer Res., 9, 2567–2575.

  • Riggins GJ and Morin PJ . (2002). The Genetic Basis of Human Cancer. Vogelstein B and Kinzler KW (eds). McGraw-Hill: New York, pp 131–141.

    Google Scholar 

  • Sawiris GP, Sherman-Baust CA, Becker KG, Cheadle C, Teichberg D and Morin PJ . (2002). Cancer Res., 62, 2923–2928.

  • Schummer M, Ng VLV, Baumgarner RE, Nelson PS, Schummer B, Bednarski DW, Hassell L, Baldwin RL, Karlan BY and Hood L . (1999). Gene, 238, 375–385.

  • Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM and Cho KR . (2002). Cancer Res., 62, 4722–4729.

  • Sherman-Baust CA, Weeraratna AT, Rangel LBA, Pizer ES, Cho KR, Schwartz DR, Shock T and Morin PJ . (2003). Cancer Cell, 3, 377–386.

  • Shimizu Y, Kamoi S, Amada S, Akiyama F and Silverberg SG . (1998). Cancer, 82, 893–901.

  • Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RC, James CD, Couch FJ, Hartmann LC, Lillie J and Smith DI . (2001). Cancer Res., 61, 5895–5904.

  • Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Praga M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S and Lifton RP . (1999). Science, 285, 103–106.

  • Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL and Feinberg AP . (1994). Nat. Genet., 7, 433–439.

  • Yin BW and Lloyd KO . (2001). J. Biol. Chem., 276, 27371–2737.

  • Yousef GM, Polymeris ME, Yacoub GM, Scorilas A, Soosaipillai A, Popalis C, Fracchioli S, Katsaros D and Diamandis EP . (2003). Cancer Res., 63, 2223–2227.

Download references

Acknowledgements

We thank the members of our laboratory for helpful comments on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrice J Morin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rangel, L., Sherman-Baust, C., Wernyj, R. et al. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 22, 7225–7232 (2003). https://doi.org/10.1038/sj.onc.1207008

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207008

Keywords

This article is cited by

Search

Quick links